One of the strangest things about psilocybin therapy is the mismatch in timing. The drug leaves the body within hours. The benefits, when they show up, can last for weeks or months. Something happens during that one session that keeps paying off long after the trip is over.
A new study from researchers at the University of Heidelberg and the University of Zurich offers a clue. They looked at whether a single dose of psilocybin changes the chemical tags that sit on top of our DNA, tags that do not change the genes themselves but change whether those genes get switched on or off. This system is called epigenetics, and the specific tags are called methylation.
What they did
Thirty seven people recovering from alcohol use disorder took part. Half received a single 25mg dose of psilocybin, half received a placebo. Researchers drew blood before the dose, the day after, and again a month later, then scanned roughly a million points on the genome to see what had shifted.
Drinking outcomes did not differ much between the two groups. But depression and hopelessness scores improved significantly more in the psilocybin group, which gave the researchers a real psychological effect to try to explain at the molecular level.
What they found
A handful of genes showed clear changes after psilocybin. The genes themselves are not the headline though. What is interesting is what those genes do.
The strongest signals were not in genes related to brain chemistry or “consciousness” in any obvious sense. They were in genes related to immunity, inflammation, and immune regulation. One gene involved in immune cell development showed a notable change in the day after dosing.
Another, the gene for the serotonin receptor psilocybin directly targets, showed a shift that researchers have previously linked to better emotional regulation. A gene tied to inflammation signalling moved too, echoing earlier findings that psilocybin lowers inflammatory markers in the blood.
This fits a pattern that has been building across psychedelic research for a while now. Psychedelics may work through two pathways at once.
Psychological pathways:
- Mystical or meaningful experiences
- Emotional breakthroughs
- Increased openness
- New perspectives on old problems
Biological pathways:
- Neuroplasticity (the brain forming new connections)
- Reduced inflammation
- Immune system changes
- Gene regulation
It’s a useful reminder that psilocybin’s reach isn’t confined to the mind. A separat 2025 study out of Emory University found that psilocybin’s active compound extended the lifespan of human cells in culture and improved survival in aged mice, working through metabolic and stress-repair pathways rather than anything to do with a trip. Psilocybin appears to act on the body as much as the brain.
Why this matters
For years, people have argued about whether psychedelics work because of the experience itself or because they physically change the body. The answer increasingly looks like both.
The experience may trigger biological changes. Those biological changes may then help the psychological changes stick. It can work like a loop:
- The experience changes perception.
- Perception changes behaviour.
- Behaviour changes biology.
- Biology reinforces the new behaviour.
Each part feeds the next.
What this does NOT prove
It’s worth being clear about the limits here. This study does not show that psilocybin permanently “rewrites your DNA”, that psilocybin cures alcohol use disorder, or that these epigenetic changes caused anyone’s recovery.
What it shows is an association, genes that moved together with psilocybin and with mood improvement, not proof of cause and effect. The study only had 37 people, which is a small sample for this kind of research, and the researchers are upfront that it needs to be repeated at a larger scale before anyone draws firm conclusions.
The deeper implication
If these findings hold up, psilocybin may act less like a typical drug and more like a signal that temporarily makes a rigid system more flexible again by loosening several systems at once: brain networks, behaviour patterns, emotional processing, immune function, and gene regulation.
Addiction is often described as a kind of rigidity, fixed habits, fixed thought patterns, fixed reward pathways that keep running the same loop no matter what. What this study hints at is that psilocybin may be acting on that rigidity at more than one level simultaneously, biological and psychological at once, rather than one cause pushing a single effect.
That’s still a hypothesis. But it’s a useful one, and it’s exactly the kind of multi-level effect that would explain why a single session can echo for so long after the molecule itself is gone.
Subscribe to the newsletter to keep up to date with the world of psychedelics, the brain, and regenerative health. Subscribe here.
